Anand Diagnostic Lab, one of India‘s oldest and leading, stand-alone diagnostic services company, launched a new drive-through blood collection ...
Sunidhi Securities is bullish on Aarti Drugs (ADL) and has recommended buy rating on the stock with a price target of Rs 260 in its June 26, 2013 research report.
Ajay K Swarup, managing director of Globus Spirits, in an interview to CNBC-TV18, gave additional details on the merger and what kind of revenue growth the company is expecting from it.